Association between insulin like growth factor-1 and lipoprotein metabolism in stable angina patients on statin therapy: A pilot study

Kardiologia Polska

Volumn 70, Issue 10, 2012, Pages 1017-1022

  Burchardt, Paweł ^a,b   Tabaczewski, Piotr ^a   Goździcka Józefiak, Anna ^c   Siminiak, Tomasz ^a   Szczepaniak, Adam ^a   Banaszak, Agnieszka ^a   Wysocki, Henryk ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b District Hospital   (Poland)

^c ADAM MICKIEWICZ UNIVERSITY   (Poland)

Author keywords

Coronary artery disease; IGF 1; Lipoprotein metabolism

Indexed keywords

EID: 84868349554     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Succurro E, Arturi F, Grembiale A et al. Positive association between plasma IGF1 and high-density lipoprotein cholesterol levels in adult nondiabetic subjects. Eur J Endocrinol, 2010; 163: 75-80.
2. Colao A, Spiezia S, Di Somma C et al. Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age. J Endocrinol Investigation, 2005; 28: 440-448. (Pubitemid 43162741)
3. Spallarossa P, Brunelli C, Minuto F et al. Insulin-like growth factor-I and angiographically documented coronary artery disease. Am J Cardiol, 1996; 77: 200-202.
4. Conti E, Andreotti F, Sciahbasi A et al. Markedly reduced insulin- like growth factor-I in the acute phase of myocardial infarction. J Am Coll Cardiol, 2001; 38: 26-32. (Pubitemid 32613824)
5. Juul A, Scheike T, Davidsen M et al. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation, 2002; 106: 939-944. (Pubitemid 34925327)
6. Laughlin GA, Barrett-Connor E, Criqui MH et al. The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. J Clin Endocrinol Metab, 2004; 89: 114-120. (Pubitemid 38183869)
7. Kaplan RC, McGinn AP, Pollak MN et al. Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke. J Clin Endocrinol Metab, 2007; 92: 1319-1325. (Pubitemid 46556404)
8. Fischer F, Schulte H, Mohan S et al. Associations of insulin-like growth factors, insulin-like growth factor binding proteins and acid-labile subunit with coronary heart disease. Clin Endocrinol, 2004; 61: 595-602. (Pubitemid 39540361)
9. Schneider HJ, Klotsche J, Saller B et al. Associations of age-dependent IGF-I SDS with cardiovascular diseases and risk conditions: crosssectional study in 6773 primary care patients. Eur J Endocrinol, 2008; 158: 153-161. (Pubitemid 351298531)
10. Burchardt P, Gozdzicka-Jozefiak A, Zurawski J et al. Are elevated levels of IGF-1 caused by coronary arteriosclerosis? Molecular and clinical analysis. Protein J, 2010; 29: 538-544.
11. Delafontaine P, Song Y-H, Li Y. Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. Arterioscler Thromb Vasc Biol, 2004; 24: 435-444. (Pubitemid 38326135)
12. Ceda GP, Dall'Aglio E, Magnacavallo A et al. The insulin-like growth factor axis and plasma lipid levels in the elderly. J Clin Endocrinol Metab, 1998; 83: 499-502. (Pubitemid 28496529)
13. Ruotolo G, Bavenholm P, Brismar K et al. Serum insulin-like growth factor-I level is independently associated with coronary artery disease progression in young male survivors of myocardial infarction: beneficial effects of bezafibrate treatment. J Am Coll Cardiol, 2000; 35: 647-654. (Pubitemid 30167021)
14. Vitko-Sarsat W, Freiedlander M, Capeillere-Blandin C et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int, 1996; 49: 1304-1313. (Pubitemid 26166404)
15. Nourooz-Zadeh J, Tajaddini-Sarmadi J, Wolff SP. Measurement of plasma hydroperoxide concentrations by the ferrous oxidation- xylenol orange assay in conjunction with triphenylphosphine. Anal Biochem, 1994; 220: 403-409.
16. Federici M, Porzio O, Lauro D et al. Increased abundance of insulin/insulin-like growth factor-I hybrid receptors in skeletal muscle of obese subjects is correlated with in vivo insulin sensitivity. J Clin Endocrinol Metab, 1998; 83: 2911-2915. (Pubitemid 28493797)
17. Cao WM, Murao K, Imachi H et al. Insulin-like growth factor-1 regulation of hepatic scavenger receptor class BI. Endocrinology, 2004; 145: 5540-5547. (Pubitemid 39564594)
18. Reiner Z, Catapano A, De Backer G et al. ESC/EAS Guidelines for the management of dyslipidaemias. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J, 2011; 32: 1769-1818.
19. Yakar S, Liu JL, Fernandez AM et al. Liver-specific IGF-1 gene deletion leads to muscle insulin insensitivity. Diabetes, 2001; 50: 1110-1118. (Pubitemid 32374542)
20. Yakar S, Setser J, Zhao H et al. Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1 - deficient mice. J Clin Invest, 2004; 113: 96-105. (Pubitemid 38541636)